Monthly Nirsevimab Receipt and Intent Among Females Aged 18-49 Years Who Have a Baby <8 Months, Are Currently Pregnant, or Are Trying to Get Pregnant.

• Using data from the National Immunization Survey-Adult COVID Module (NIS-ACM), monthly estimates of receipt and intent for baby’s receipt of nirsevimab reported by females aged 18-49 years with infants under the age of 8 months, females aged 18-49 years who are currently pregnant, and females aged 18-49 years who are currently trying to get pregnant.

• The NIS-ACM is an ongoing random-digit-dial cellular telephone survey of households with adults 18 years and older.

Tags: pregnancy, nis-acm, rsv vaccination

Last updated: 2024-01-10 19:04:52+00:00